Skip to main content

Table 1 Comparisons of patients’ demographics and preoperative clinical characteristics between the two groups

From: Efficacy analysis of self-help position therapy after holmium laser lithotripsy via flexible ureteroscopy

Variables, mean ± SD or n (%)

Position group (n = 220)

Control group (n = 428)

P value

Age, year

46.4 ± 5.3

44.1 ± 3.7

0.782

BMI, kg/m2

22.1 ± 2.7

23.3 ± 1.5

0.635

Gender

 Male

123 (55.9)

222 (51.9)

 Female

97 (44.1)

206 (48.1)

0.329

Hypertension history

 No

160 (72.7)

328 (76.6)

 Yes

60 (27.3)

100 (23.4)

0.275

Diabetes history

 No

201 (91.4)

383 (89.5)

 Yes

19 (8.6)

45 (10.5)

0.448

Stone size, cm

  < 1.0 cm

37 (16.8)

106 (24.8)

 1.0–2.0 cm

109 (49.6)

218 (50.9)

0.108

 2.0–2.5 cm

74 (33.6)

104 (24.3)

0.003**

Stone locations

 Pelvis or upper calyx

83 (37.7)

166 (38.8)

 Middle calyx

33 (15.0)

101 (23.6)

0.077

 Lower calyx

104 (47.3)

161 (37.6)

0.164

ESWL history

 No

115 (52.3)

245 (57.2)

 Yes

105 (47.7)

183 (42.8)

0.228

Nephrolithiasis operation historiesa

 No

164 (74.5)

297 (69.4)

 Yes

56 (25.5)

131 (30.7)

0.170

Preoperative hydronephrosis

 No

163 (74.1)

351 (82.0)

 Yes

57 (25.9)

77 (18.0)

0.018*

Preoperative lower calyceal seeper

 No

146 (66.4)

324 (75.7)

 

 Yes

74 (33.6)

104 (24.3)

0.012*

Preoperative renal function

 Normal

199 (90.5)

394 (92.0)

 Abnormal

21 (9.5)

34 (8.0)

0.488

Double-J stents placed histories

 No

140 (63.6)

288 (67.3)

 Yes

80 (36.4)

140 (32.7)

0.352

  1. BMI body mass index, SD standard deviation, ESWL extracorporeal shock wave lithotripsy
  2. aNephrolithiasis operation histories include flexible ureteroscope lithotripsy, percutaneous nephrolithotomy or nephrolithotomy
  3. *p < 0.05, **p < 0.01